img

Sign Up For Email Updates:

AICR Blog loading...
More from the blog »
WCRF/AICR
Global Network

Epigallocatechin-3-gallate for Enhancement of Cisplatin Therapy (2006)

Title:

Epigallocatechin-3-gallate for Enhancement of Cisplatin Therapy

Key words:

green tea, EGCG, cisplatin, AP-1, NF-?B, glutathione

Research Institution:

Temple University

Location:

Pennsylvania

Researcher:

Marion M Chan

Project Description:

This study determined whether EGCG, a major component of green tea, sensitises ovarian cancer cells to cisplatin treatment by inhibiting detoxifcation of cisplatin through inactivation of AP-1 and NF-?B pathways that could lead to the depletion of glutathione.

Cancer Site(s)

Related Foods that Fight Cancer

Questions: Ask Our Staff

Talk to us!

Our planned giving staff is
here to help you!

Richard Ensminger

Richard K. Ensminger

Director of Planned Giving

Ann Wrenshall Worley

Ann Wrenshall Worley

Assistant Director of Planned Giving

Call Us: (800) 843-8114

Send us a note